Tracleer
Jobs under threat in Actelion cost saving
July 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts
Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …
Actelion boosted by trial success
April 30, 2012Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan
Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial. The news comes after …
Actelion defends itself against investor aggression
March 9, 2011Sales and Marketing Actelion, Tracleer, almorexant
Swiss biotech firm Actelion is mounting a defence of its management board and strategy following an offensive by a shareholder …
Tracleer continues to fuel Actelion growth
February 19, 2010Sales and Marketing Actelion, Tracleer
Actelion has posted a 20% increase in revenue on the strength of its pulmonary hypertension treatment Tracleer. The drug saw …
Tracleer expansion fuels Actelion growth
July 22, 2009Sales and Marketing Actelion, Tracleer
Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
